4//SEC Filing
HeartWare International, Inc. 4
Accession 0001209191-14-019933
CIK 0001389072operating
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:24 PM ET
Size
14.4 KB
Accession
0001209191-14-019933
Insider Transaction Report
Form 4
Hathaway David R
Chief Medical Officer
Transactions
- Sale
Common Stock
2014-03-10$95.00/sh−1,601$152,095→ 0 total - Sale
Common Stock
2014-03-11$95.00/sh−2,812$267,140→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2014-03-11−2,812→ 0 totalExercise: $18.02From: 2012-08-13Exp: 2018-08-13→ Common Stock (2,812 underlying) - Exercise/Conversion
Common Stock
2014-03-10$18.08/sh+299$5,406→ 1,601 total - Exercise/Conversion
Common Stock
2014-03-11$18.02/sh+2,812$50,672→ 2,812 total - Exercise/Conversion
Stock Option (right to buy)
2014-03-10−299→ 2,812 totalExercise: $18.08From: 2012-08-13Exp: 2018-08-13→ Common Stock (299 underlying)
Footnotes (4)
- [F1]The purchase price of US$18.08 has been converted from AU$19.95 at the spot rate on the date of the transaction.
- [F2]The purchase price of US$18.02 has been converted from AU$19.95 at the spot rate on the date of the transaction.
- [F3]The exercise price of US$18.08 has been converted from AU$19.95 at the spot rate on the date of the transaction.
- [F4]The exercise price of US$18.02 has been converted from AU$19.95 at the spot rate on the date of the transaction.
Documents
Issuer
HeartWare International, Inc.
CIK 0001389072
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389072
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:24 PM ET
- Size
- 14.4 KB